Literature DB >> 22717091

Diffusion into human islets is limited to molecules below 10 kDa.

S J Williams1, T Schwasinger-Schmidt, D Zamierowski, L Stehno-Bittel.   

Abstract

Isolated islets are important tools in diabetes research and are used for islet transplantation as a treatment for type 1 diabetes. Yet these cell clusters have a dramatic diffusion barrier that leads to core cell death. Computer modeling has provided theoretical size limitations, but little has been done to measure the actual rate of diffusion in islets. The purpose of this study was to directly measure the diffusion barrier in intact human islets and determine its role in restricting insulin secretion. Impeded diffusion into islets was monitored with fluorescent dextran beads. Dextran beads of 10-70 kDa failed to diffuse into the core of the intact islets, while 0.9 kDa probe was observed within the core of smaller islets. Diffusion of the fluorescent form of glucose, 2-NBDG, had similar diffusion limitations as the beads, with an average intra-islet diffusion rate of 1.5 ± 0.2 μm/min. The poor diffusion properties were associated with core cell death from necrosis, not apoptosis. Short-term exposure to a mild papain/0 Ca(2+) cocktail, dramatically reduced the diffusion barrier so that all cells within islets were exposed to media components. Lowering the diffusion barrier increased the immediate and long-term viability of islet cells, and tended to increase the amount of insulin released, especially in low glucose conditions. However, it failed to improve the large islet's glucose-stimulated insulin secretion. Thus, the islet diffusion barrier leads to low viability and poor survival of large islets, but is not solely responsible for the reduced insulin secretion of large isolated islets.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22717091     DOI: 10.1016/j.tice.2012.05.001

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  9 in total

1.  Hyaluronic Acid/Collagen Hydrogel as an Alternative to Alginate for Long-Term Immunoprotected Islet Transplantation<sup/>.

Authors:  Stephen Harrington; Janette Williams; Sonia Rawal; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  Tissue Eng Part A       Date:  2017-03-02       Impact factor: 3.845

2.  Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice.

Authors:  Kenjiro Kumano; Hitomi Nishinakamura; Toshiyuki Mera; Takeshi Itoh; Hiroyuki Takahashi; Toshiyoshi Fujiwara; Shohta Kodama
Journal:  Islets       Date:  2016-09-02       Impact factor: 2.694

3.  Assessment of re-aggregated human pancreatic islets for secondary drug screening.

Authors:  K Ramachandran; X Peng; K Bokvist; L Stehno-Bittel
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

4.  Controlled aggregation of primary human pancreatic islet cells leads to glucose-responsive pseudoislets comparable to native islets.

Authors:  Janneke Hilderink; Siebe Spijker; Françoise Carlotti; Lydia Lange; Marten Engelse; Clemens van Blitterswijk; Eelco de Koning; Marcel Karperien; Aart van Apeldoorn
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

5.  Improved yield of canine islet isolation from deceased donors.

Authors:  Stephen Harrington; S Janette Williams; Vern Otte; Sally Barchman; Cheryl Jones; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  BMC Vet Res       Date:  2017-08-22       Impact factor: 2.741

6.  Glucose, adrenaline and palmitate antagonistically regulate insulin and glucagon secretion in human pseudoislets.

Authors:  Estela Lorza-Gil; Felicia Gerst; Morgana Barroso Oquendo; Ulrich Deschl; Hans-Ulrich Häring; Mario Beilmann; Susanne Ullrich
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

7.  A Versatile Microencapsulation Platform for Hyaluronic Acid and Polyethylene Glycol.

Authors:  Stephen Harrington; Lindsey Ott; Francis Karanu; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  Tissue Eng Part A       Date:  2020-03-27       Impact factor: 3.845

8.  KU-32, a novel drug for diabetic neuropathy, is safe for human islets and improves in vitro insulin secretion and viability.

Authors:  Kevin Farmer; S Janette Williams; Lesya Novikova; Karthik Ramachandran; Sonia Rawal; Brian S J Blagg; Rick Dobrowsky; Lisa Stehno-Bittel
Journal:  Exp Diabetes Res       Date:  2012-11-01

9.  Small human islets comprised of more β-cells with higher insulin content than large islets.

Authors:  Bilal Farhat; Akshay Almelkar; Karthik Ramachandran; S Janette Williams; Han-Hung Huang; David Zamierowksi; Lesya Novikova; Lisa Stehno-Bittel
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.